Ohio State University has signed up to a spinout-focused life sciences venture vehicle run by regional firm Rev1 Ventures that stands at three times the size of its precursor.
Ohio State University (OSU) and Nationwide Children’s Hospital (NCH) have joined seed-stage venture firm Rev1 Ventures as investors in a new $15m fund geared towards life sciences spinouts and other businesses.
Rev1 Catalyst Fund II aims to supply critical-stage funding and assistance to healthcare projects surrounding Columbus, central Ohio, home to both of its limited partners.
The fund is almost three times larger than its precursor, Rev1 Life Sciences Fund I, which raised $5.5m from Rev1 Ventures and…
